Abbott Laboratories (NYSE:ABT) is a healthcare company that discovers, develops, manufactures, and sells a range of ...

Oppenheimer upgraded Microsoft's (MSFT) rating to Outperform from Perform and set a $600 price target, spotlighting the U.S. tech giant's AI opportunity.